Chiesi Group, an international biopharmaceutical company focused on research, recently launched operations at its Biotech Center of Excellence in Parma, Italy. This state-of-the-art facility is dedicated to developing and producing monoclonal antibodies, enzymes, and other proteins.   This facility offers an integrated approach, housing the entire supply chain, from the production of drug substances from mammalian cells to their transformation into drug products and final packaging, in a...